Auro Pharmacies Methyl-Cobalamin Injectables Recall: Sterility Risk
Auro Pharmacies recalls methyl-cobalamin injectables (5mL and 30mL vials) due to lack of sterility assurance. Products may cause infection if used improperly.
Lower-risk recall
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Contact the company
What happened, in plain English
Auro Pharmacies is recalling methyl-cobalamin injectable products because their manufacturing processes didn't properly ensure sterility. This could lead to infections if the products are used. Read more at govinfonow.com/recall/39694-auro-pharmacies-methyl-cobalamin-injectables-recall-sterility-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39694-auro-pharmacies-methyl-cobalamin-injectables-recall-sterility-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-1160-2018
Cite this page
“Auro Pharmacies Methyl-Cobalamin Injectables Recall: Sterility Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39694-auro-pharmacies-methyl-cobalamin-injectables-recall-sterility-risk. Based on FDA recall #D-1160-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1160-2018%22&limit=1).
Why it’s dangerous
The products were made without proper sterility checks, meaning they could contain harmful bacteria. If injected, this could cause infections or other health issues.
Who’s affected
Prescription drug users who received the specific vial sizes and lot numbers from Auro Pharmacies' compounding pharmacy in La Habra, California. Healthcare providers and patients using these injectables are most at risk.
How to tell if you have this one
Check for vials labeled 'Methyl-Cobalamin injectable, 1 mg/mL' in 5mL or 30mL sizes. The lot number is 180618/2 with an expiration date of September 16, 2018.
- Brand
Auro Pharmacies- Category
Drug
All 12 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide in USA
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1156-2018 | CoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180626/3, Exp 25-Aug-18 | 39 vials |
| D-1157-2018 | Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180626/10, Exp 24-Sep-18 | 167 vials |
| D-1158-2018 | Dexpanthenol injectable, 250 mg/mL, 10 mL Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180529/2, Exp 27-Aug-18 and 180620/11, Exp 18-Sep-18 | 91 vials |
| D-1159-2018 | Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180716/21, Exp 14-Oct-18 | 183 vials |
| D-1160-2018 | Methyl-Cobalamin injectable, 1 mg/mL, packaged in a) 5 mL and b) 30 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: a) 180618/2, Exp 16-Sep-18; b) 180618/2, Exp 16-Sep-18 | 114 vials |
| D-1161-2018 | Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180618/3, Exp 16-Sep-18 | 90 vials |
| D-1162-2018 | Methyl-Cobalamin injectable, 10 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180702/1, Exp 30-Sep-18 | 81 vials |
| D-1163-2018 | Testosterone Cypionate/Enanthate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180709/21, Exp 07-Sep-18 | 43 vials |
| D-1164-2018 | Testosterone Cypionate/Enanthate injectable, 200/50 mg/mL, packaged in a) 5 mL and 8 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180606/18, Exp 30-Nov-18 | 32 vials |
| D-1165-2018 | Testosterone Enanthate/Cypionate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180709/24, Exp 07-Sep-18 | 11 vials |
| D-1166-2018 | Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180611/1, Exp 09-Sep-18 | 40 vials |
| D-1167-2018 | Methyl-Cobalamin injectable, 2 mg/mL, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631; Lot #: 180620/2, Exp 18-Sep-18 | 74 vials |
What to do — step by step
Check Vial Details
Look for vials with the lot number 180618/2 and expiration date September 16, 2018.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1160-2018 (August 21, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1160-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.